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Abstract
Leishmania devices its survival strategy by suppressing the host’s immune functions. The antigen molecules
produced by Leishmania interferes with the host’s cell signaling cascades and consequently changes the protein
expression pattern of the antigen-presenting cell (APC). This creates an environment suitable for the switching of
the T-cell responses from a healing Th1 response to a non-healing Th2 response that is favorable for the continued
survival of the parasite inside the host APC. Using a reconstructed signaling network of the intracellular and
intercellular reactions between a Leishmania infected APC and T-cell, we propose a computational model to predict
the inhibitory effect of the Leishmania infected APC on the T-cell and to identify the regulators of this Th1-/Th2-
switching behavior as observed during Leishmania infection. In this work, we hypothesize that a complete removal
of the parasite could only be achieved with a simultaneous up-regulation of the healing Th1 response and
stimulation of nitric oxide (NO) production from the APCs, and downregulation of the non-healing Th2 response
and thereby propose several unique combinations of protein molecules that could elicit this anti-Leishmania
immune response. Our results indicate that TLR3 may play a positive role in eliciting NO synthesis, while TLR2 may
be responsible for inhibiting an anti-Leishmania immune response. Also, TLR3 overexpression (in the APC), when
combined with SHP2 inhibition (in the T cell), produces an anti-Leishmania response that is better than the
conventional IFN-gamma or IL12 treatment. A similar anti-Leishmania response is also obtained in another
combination where TLR3 (in APC) is overexpressed, and SHC and MKP (of T cell) are inhibited and activated,
respectively. Through our study, we also observe that Leishmania infection may induce an upregulation of IFN-beta
production from the APC that may lead to an upregulation of the RAP1 and SOCS3 proteins inside the T cell, the
potential inhibitors of MAPK and JAK-STAT signaling pathways, respectively, via the TYK2-mediated pathway. This
study not only enhances our knowledge in understanding the Th1/Th2 regulatory switch to promote healing
response during leishmaniasis but also helps to identify novel combinations of proteins as potential
immunomodulators.
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1 Introduction
Cell-mediated immunity (CMI), responsible for con-
fronting the infections caused due to invasion of intra-
cellular pathogens, primarily involves the interactions
of the phagocytic antigen-presenting cells (APCs) and
the T-lymphocytes. This leads to the activation of a
series of intra-cellular and inter-cellular biochemical
signaling processes, which culminates into synthesis of
certain diffusible effector molecules that includes pro-
teins (mostly the cytokines) and microbicidal molecules
(e.g., nitric oxide) helping in the clearance of the dis-
ease [1]. However, the activities of this defense mechan-
ism are severely compromised during leishmaniasis, a
neglected tropical disease, caused due to infection by
the protozoan parasites of the genus Leishmania. This
is transmitted to the human through the infected bites
of the phlebotomine sand flies during their blood meal
[1]. The promastigote form of the parasite, once
injected into the human host, is engulfed by the APC
(macrophages and dendritic cells) to form a phagolyso-
some, where it differentiates into its amastigote form
and takes control of its entire cellular machineries in a
way that reduces the immuno-competency of the im-
mune cells thereby hindering the body’s natural parasite
clearance process [2].
The surface molecules produced by Leishmania, such
as, lipophosphoglycan (LPG), glycoprotein 63 (GP63),
and the elongation factor EF1-alpha directly or indirectly
activate a series of phosphatases inside the human APCs
(e.g., SHP1, PTP1B, and TCPTP), that leads to dephos-
phorylation and de-activation of important signaling
molecules inside the host cell [3]. Inside the APC, the
LPG molecules act as antigens and are presented to the
surrounding T-lymphocytes to elicit either of the two
types of immune responses, viz. healing and non-healing
responses, depending on the parasite load and the host
immunity [4]. The healing response is obtained in case
of low parasitic load, in which a pronounced Type-I
helper T-cell (or Th1) response occurs due to up-
regulation of the Th1 cytokines, such as the interferon-
gamma from the stimulated T cells, and thus naturally
clears the pathogen from the system [1, 5]. On the other
hand, higher pathogen load gives rise to a non-healing
response in which an upregulation of the Th2 cytokines
(e.g., IL10) is observed, that favors the persistence of the
Leishmania. Simultaneously, during this non-healing re-
sponse, the production of the protective Th1 cytokines,
such as IL12, and the microbicidal molecules, such as
nitric oxide is also downregulated, thus creating an
immune-suppressed condition suitable for the further
progression of the disease [6].
It is experimentally shown that all types of leishmania-
sis viz. cutaneous, muco-cutaneous, and visceral leish-
maniasis elicit these types of immune responses in
human body [7]. Hence, the general therapeutic strategy
adopted for the treatment of Leishmaniasis is primarily
aimed to expedite the process of parasite clearance for
faster healing by stimulating the Th1 or healing re-
sponse. In case of cutaneous leishmaniasis therapeutics,
chemotherapeutic drugs, such as pentavalent antimo-
nials, liposomal amphotericin B has been shown to be
useful to reduce the dermal lesions and the chances of
further destructive mucosal inflammations and visceral
infections [8, 9]. However, the successive clinical studies
have shown that these chemotherapeutic drugs are also
associated with adverse side effects, such as nausea, in-
tense headache, diarrhea, musculoskeletal and abdom-
inal pain etc. [9–13]. In several cases, relapse of the
disease and developing resistant strains are also reported
after the use of these drugs, which necessitates the
development of better treatment protocols with higher
clinical efficacy [14]. Although immunotherapeutic
strategies involving the administration of exogenous
interferon-gamma is found to be effective in suppressing
leishmaniasis [15, 16], the high production of IL10 dur-
ing early stage of infection often suppresses its activity,
thereby hindering NO production and disease clearance
[17]. Based on these experimental outcomes, a number
of mathematical models have also been proposed simul-
taneously to untangle the complexities that appear as
hurdles to device a successful treatment strategy in
leishmaniasis [18, 19]. In one of such studies, “granu-
lomas” formation during Leishmania donovani infection
has been modeled using Petri net analysis by considering
the inter-cellular interactions of macrophage, lympho-
cyte, NK cells etc. The outcomes of these cell population
based models have emphasized cytokine therapy by the
exogenous injection of interferon-gamma and the sup-
pression of IL10 to eradicate the Leishmania pathogens
in macrophage cell [20]. However, interferon-gamma
molecule is a pro-inflammatory molecule and also has
short half-life time, which in turn requires its repeated
administration into the body at a regular interval of time
that may have harmful consequences [21, 22]. Hence, to
circumvent these problems, implementation of better
therapeutic strategies, by identifying novel drugs, drug
target molecules and immunostimulators are required
and demands higher attention from the vast majority of
clinical and experimental pharmacologists.
However, in order to develop an effective immunothera-
peutic strategy, it is important to have a comprehensive un-
derstanding of the Th1/Th2 dichotomy in leishmaniasis so
as to identify the regulators through which the Th1/Th2
switching behavior can be effectively controlled. This mech-
anism still remains very less explored. The identification of
such important molecular switch and their corresponding
reaction routes through which the immunostimulation
could be enhanced is highly required in this field of study.
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As the exact intra-cellular reaction cascades governing the
Tcell response after encountering with Leishmania infected
APCs is not clearly understood yet, the mechanisms
through which this response dynamics and the nitric oxide
(NO) production work in the immune cells is still un-
known. Besides, the mechanism through which the Leish-
mania antigens override the APCs intra-cellular network
by varying the expressions of the immunostimulatory pro-
teins, and force to redirect the immune responses towards
the non-healing or Th2 response is not comprehensively
studied yet. The study of these regulatory mechanisms by
analyzing such a large system using conventional experi-
mental techniques is time consuming and also difficult to
perform, and therefore in silico mathematical models of
inter and intra-cellular reaction cascades in APC and T cell
in presence of Leishmania antigens would probably be the
best strategy to counteract these problems. This may also
help to address some of the unexplored questions of Leish-
mania immunotherapy, such as the limitations of the
interferon-gamma treatment, the reason for which
interferon-beta treatment is only effective at low doses, and
the means by which the toll-like receptor (TLR) molecules
expressed by the APCs can regulate the immune responses
of the T cell to shift the dynamics towards a higher healing
Th1 response [17, 23–25].
In this study, we have tried to address the above
mentioned problems in Leishmania major infection
scenario by using mathematical model and in silico ana-
lysis. We have hypothesized that in order to achieve
better therapeutic results without adverse side effects,
the stimulation of type-I T-helper cells and a simultan-
eous upregulation of NO production by using immu-
nostimulator would be the best therapeutic strategy to
clear the Leishmania pathogens from the body. In order
to develop a suitable in silico model that may enhance
our understanding of Leishmania immunobiology, we
have manually reconstructed a comprehensive cell
signaling pathway map of a Leishmania infected APC
and a normal CD4+ T cell (helper T cell), considering
the important physical interactions and the cross-talks
by the secreted diffusible molecules between the two
cells. The Leishmania infection has been introduced in
the model by establishing the interaction of the Leish-
mania antigens, known from the literature and data-
bases, with the appropriate host protein molecules in
the APC. However, the dynamic analysis of such a large
network is difficult to perform due to the unavailability
of kinetic parameters and concentration values. Hence,
to assess the gene or protein expression patterns of
large scale signal transduction networks under different
pathological conditions, the concept of discrete dy-
namic Boolean or logical modeling approach has been
utilized successfully [26–28]. Large scale, intracellular
T cell signaling network is also analyzed by using this
modeling technique and eventually various structural
and functional properties of this network under normal
and disease conditions are studied successfully [29, 30].
A logic-based modeling technique is also applied to
analyze the temporal expression patterns of the genes/
proteins of T cell, which are strongly influenced by the
intra-cellular T cell signal transduction cascade in pres-
ence or absence of infection [31].
Here, the entire reaction mechanisms are translated
into logical equations with the objective to simulate and
understand the effect of the presence and absence of the
Leishmania antigens on the signaling events of the host’s
APCs and T cells. Followed by the Boolean attractor
analysis and the successful validation of the simulation
outcomes with the time-course microarray expression
data as well as the phenotypic responses obtained from
published experimental observations, the model is then
used to compare the protein expression pattern for nor-
mal and Leishmania-infected scenarios. With an aim to
understand the mode of regulations that occur due to
the infection at the molecular level inside the T cell, the
comparison of the two scenarios is then used to extract
the important T cell proteins, which are highly influ-
enced under the pathogen burden. The result of this
analysis is further used to predict the unknown changes
occurring at the pathway level in the T cell during infec-
tion. Moreover, the knowledge of these deregulated
pathways is thereafter used to predict the targets for the
in silico perturbation analysis. Perturbations of the lo-
gical states of proteins in the network are performed to
study the effect of the known immunostimulants (viz.
IL12 and interferon-gamma) as well as to propose some
new combinations of molecules that act as a molecular
switch to regulate the Th1/Th2 and NO response dy-
namics. Subsequently, these identified novel combina-
tions of proteins were tested for stability and robustness
by examining the attractors of the system under these
perturbations. Thereafter, it was ascertained that the
proposed combinations of protein targets can be used as
the potential immunomodulators, targeting of which
may bypass the inhibitory activities of the pathogens and
enhance the anti-Leishmania immune responses as well
as the microbicidal activities of the body’s immune cells.
2 Materials and methods
2.1 Construction of gene correlation network
Gene correlation networks of the significantly expressed
genes, observed in two independent microarray experi-
ments for APC (E-GEOD: 42088) and T cell (E-GEOD:
48978), were constructed in this work by calculating the
Pearson correlation coefficient of each pair of genes from
the temporal gene expression data followed by the calcula-
tion of P values. The P values of all pair of genes from the
two microarray data sets were stored in symmetric square
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matrices from which the corresponding adjacency matri-
ces were generated. In the adjacency matrices, the
elements are either 1 (P value < 0.01) or 0 (otherwise).
These adjacency matrices are then used for the construc-
tion of co-expression or correlation networks of the two
microarray gene expression datasets. The networks are
then analyzed for the identification of probable clusters
(or functional modules) in Cyctoscape (version 2.8) GPU
based App AllegroMCODE (version 2.1) [32]. The genes
from each functional module identified in this analysis are
further used for the pathway enrichment analysis in
bioCompendium (http://biocompendium.embl.de/) and
GeneCodis [33] web servers [Additional file 1: Text S1/
Table S1 and Text S2/Table S2]. The pictorial representa-
tions of each cluster are provided in Additional file 2:
Figure S1 and Additional file 3: Figure S2.
2.2 Pathway reconstruction/integration
In order to capture the functional regulations that oper-
ate between these significantly enriched pathways within
the two cells, i.e., APC and T cell, reconstruction of a
comprehensive map of signaling processes depicting the
effect of Leishmania infection on immune response was
necessary. Hence, a detailed T cell and APC interaction
pathway diagram was created after a thorough study of
existing literatures and databases. Protein-protein inter-
action (PPI) and the biochemical signal transduction
data were collated from various cell signaling and PPI
databases, such as KEGG, Protein Lounge, Pathway Cen-
tral, Biocarta, NetPath, BIOGRID, etc. and various pub-
lished research articles [34–37]. The Leishmania
proteins were then introduced in the network and the
interactions of these proteins were established with the
existing APC molecules depending on the biological evi-
dences [38–40]. The Leishmania antigenic molecules
used in the model, viz. LPG_L, GP63_L, LFAA_L, and
EF1_ALPHA_L, are known to be present in almost all
the Leishmania species so as to create a generalized
Leishmania infection model (LFAA_L is a hypothetical
molecule which we considered in our model to show the
activation of ASMASE for the production of CER-
AMIDE [41]; it is abbreviated for Leishmania factor acti-
vating ASMASE). With certain modifications (required
to build the juxtacrine and paracrine interactions be-
tween the cells), the T cell pathway reported in our pre-
vious work was used to understand the T cell-APC
cross-talks and to monitor the immunological response
generated during Leishmania infection [31]. The path-
way figure was drawn using Cell Designer software (ver-
sion 4.3) [42]. The signaling molecules (nodes) and
interactions were color coded in accordance with cellu-
lar locations and their chemical nature, respectively.
Also, in order to differentiate the redundant Leishmania
and T cell molecules from the APC molecules, the
names of the protein/non-protein molecules were de-
noted with suffix “L” and “T” for Leishmania and T cell,
respectively (Additional file 4: Figure S3 and Additional
file 1: Text S3).
2.3 Model formulation
The interactions of the entire network, including all im-
portant regulations between T cell and APC, were trans-
lated into logical equations (signifying reactions or hyper
acrs) using the AND, OR, and NOT logical gates, in a
biologically meaningful way (Additional file 1: Text S5).
In order to capture the regulations at the post-
transcriptional level, the alternatively spliced isoforms of
the T cell and APC output molecules with known func-
tions have been also included in our model (Additional
file 1: Text S4/Table S3). Here, the selection of isoforms
is based on the presence of certain cis-regulatory ele-
ments and trans-acting factors that have been collect-
ively referred to as “FACTORi” where {i = 1,2,.....23}.
These 23 FACTORi represent specific spliceosomes re-
sponsible for the splice site recognition in each case.
The model was simulated synchronously (i.e., all equa-
tions updated simultaneously) and asynchronously (i.e.,
random execution of the equations) using BooleanNet-
1.2.4 software until the steady state is reached [43]. In this
model, we also defined three functions, viz. “TH_1_re-
sponse*”, “TH_2_response*”, and “NO_response*”, which
reflect the type of T cell responses elicited and production
of NO from the APC in response to an infection (Eqs. 1,
2, and 3; * denotes the (t+1)th logical state of the re-
sponses). The molecules used for defining these functions
are principally the molecules involved in eliciting these re-





TH–2–response  ¼ IL4–TAND IL5–TAND IL6–TAND IL10–T
ð2Þ
NO–response ¼ NO ð3Þ
2.4 Boolean attractor, experimental data and validation
The Boolean attractors of the model were determined by
generating all possible combinations (ON or OFF) of the
51 input molecules of the system. The simulation was
repeated for 20 samples, where 7 proteins have been se-
lected from a uniform random distribution of 51 input
molecules, thereby generating 27 × 20 (=2560) combina-
tions of input molecules. However, due to lack of human
cell-specific Leishmania major-infected RNA seq data of
APC, the logical states (activation or inactivation) of the
FACTORi determining that alternative splicing of the
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output molecules could not be explicitly determined in
Leishmania-infected scenario. Hence, in our model,
these FACTORi were assumed to be ON in all our simu-
lations, signifying that all the alternative isoforms have
equal probability of getting expressed. The analysis was
performed separately for the uninfected and the infected
scenarios, which were created by initializing the Leish-
mania antigen molecules OFF and ON, respectively, in
the two cases using synchronous Boolean update rules.
Thereafter, the steady state logical values (i.e., attractor) of
all the 294 nodes in 2560 different input combinations
from both the scenarios were identified by using in-built
functions available in BooleanNet-1.2.4 and the in house
code written in Perl script. However, to present these
attractor(s) of each sample in a simplified way, only the
steady state binary values of the ten macrophage output
molecules (viz. IFN_BETA, IL1_ALPHA, IL1_BETA, IL10,
IL12, INOS, IP10, NO, TNF_ALPHA, and c_FOS) were
plotted from each attractor(s) state using the network
visualization software Gephi (http://gephi.github.io/) and
were successively tested for the presence of multiple
attractors in the system in uninfected and infected scenar-
ios. On the other hand, the differential activation of the
FACTORi in splicing mechanism and its role in the regu-
lation of the network dynamics is further analyzed and
discussed in Additional file 1: Text S4 and Additional file
5: Figure S4.
Furthermore, in order to validate our model with
experimental data, time-course microarray expression
data for the two cells (viz. T cell and APC) were ob-
tained from two separate experiments from the EBI
ARRAYEXPRESS database (E-GEOD: 48978 and 42088,
for T cell and APC, respectively) [45]. In these micro-
array experiments, expression profile of activated hu-
man T-helper cell (Affymetrix HT HG-U133+ PM
Array Plate) and Leishmania major infected dendritic
cells (Affymetrix HG-U133 Plus 2.0 Gene Chip) were
studied at discrete time-points [46, 47]. In our analysis,
we only considered the expression values at four time-
points, i.e. 0, 2, 4, and 6-h time-points for T-cell and 0,
2, 4, 8-h time-points for dendritic cells. These expres-
sion data were then extracted and binarized using the
BOOLNET software that employs K-means clustering
algorithm [48]. The zeroth hour-binarized data was
used to initialize all the nodes of the respective cells,
with either ON or OFF depending on whether the pro-
tein shows an up-regulation or a down-regulation at
the zeroth hour (BooleanNet Software uses TRUE and
FALSE for ON and OFF, respectively; Additional file 1:
Text S6). The initial values of the Leishmania proteins
were considered ON in the infected scenario and OFF
in the uninfected scenario. The model was then simu-
lated using the synchronous update rule and validated
by comparing the expression of the ten APC output
molecules in the infected scenario with the binarized
time-course microarray data of the APC [46]. However,
it should be noted that the experimental data for the
expression of NO molecule is considered as propor-
tionate to the expression values of INOS of the micro-
array data. The model reached its steady state at the
19th time-step in the infected scenario. As a control of
the experiment an uninfected scenario was also created.
However, to calibrate the four experimental time-points
used in microarray data (i.e. 0, 2, 4, and 6 h) with the
discrete time points of our simulation results, logical
states of the proteins up to 24 discrete time-steps were
considered in this analysis (after comparing the steady
state values for both the experimental and simulation
results). Thus, a 1-h duration of experimental data was
associated by three time-steps of the simulations. The
temporal expression profile of the ten output molecules
were plotted till the 24th step (i.e., 8 h of experimental
data). It is to be mentioned here that since the expres-
sion of the output proteins is the best reflection of
functioning of the entire signaling cascade, the valid-
ation of these previously mentioned ten output mole-
cules is assumed to be sufficient to demonstrate the
authenticity of the entire model. The T cell model was
also validated in a similar way, i.e., by comparing the
time-course expression profile of the output protein
molecules as obtained in the synchronous simulation
with the experimental data [31].
2.5 Model analysis and perturbation studies
The model was simulated asynchronously (until steady
state was reached) to make a qualitative analysis of
differences in the expression profiles and functional
responses of the APC and T cell output molecules in
the infected and the uninfected scenarios. The model
was iterated 100 times, and the average values of all
the simulations at each time-point were plotted for
further analysis. This analysis also helped us to moni-
tor the small fluctuations in the expression pattern of
the pathway species over time, which occurs due to
the stochasticity in the execution of the pathway reac-
tions inside the cell. The asynchronous simulation also
ensures that the errors in the synchronous simulations
as well as attractor analysis (through selection of inde-
pendent random samples) are minimized and further pre-
sents an average behavior of the entire system over time.
In order to unravel the effect of Leishmania infection on
the entire T cell signaling cascade at the individual protein
level, and then to understand the changes at the pathway
level, two-tailed Mann-Whitney U test was carried out on
the expression of the 163 T cell intermediate and output
molecules. This helped us to identify the proteins that get
significantly de-regulated during the infection (at 5 % level
of significance). Thereafter, the model was used to predict
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the phenotypic responses (using Eqs. 1, 2, and 3) in vari-
ous treatment scenarios using several gene knock-in
and knock-out experiments created in silico by trying
different combinations of ON and OFF of the protein
molecules using the in-built “boolean2.modify_states”
function of the BooleanNet-1.2.4 software [43]. In
order to further confirm the robustness of our pre-
dicted combinations of immunotherapeutic targets,
Boolean attractor analysis was performed for the per-
turbation scenarios by varying the input molecules of
the model (as mentioned earlier). Logical steady states
of all the 296 nodes of the model from different sce-
narios (i.e., uninfected, infected and perturbed) were
identified and out of these steady state sequences,
only the steady state values of NO, Th1, and Th2 re-
sponses were extracted for the comparisons of the ef-
fect of different perturbations in the infected scenario.
Hence, following this methodology, this study aims to
find the effectiveness of our proposed treatment strat-
egies to revert the infected scenario to an infection-
free attractor similar to the uninfected scenario.
3 Result
3.1 Pathway enrichment analysis
The gene clusters identified from the co-expression net-
works of the two microarray expression data sets can be
considered as the “functional modules” of the gene inter-
action networks of the Leishmania major infected APC
and the activated T cell, respectively. A total of 10 and
24 clusters or functional modules are found from the
gene co-expression networks of APC and T cell, respect-
ively (Additional file 2: Figure S1 and Additional file 3:
Figure S2). Pathway enrichment analyses of the genes
found in these clusters have identified various important
intracellular signaling pathways (e.g., cytokine-cytokine
receptor, toll-like receptor, JAK-STAT, MAPK, mTOR, T
cell receptor, calcium signaling, PI3 kinase, interleukin
signaling pathways etc.) of two different cells. The
complete list of the pathways found to be enriched in
this analysis for APC and T-cell are given in Additional
file 1: Text S1/Table S1 and Text S2/Table S2, respect-
ively. These enriched pathways, corresponding to the
significantly expressed genes of APC and T cell micro-
array expression data sets, represent the pathways that
are influenced by the Leishmania pathogen in the APC
and in the activated T cell. However, it should be noted
that the pathways found to be enriched in this analysis
do not to provide the complete understandings of the
molecular mechanisms through which the pathogen
infect the APCs. Also, we are unable to capture the
dynamic interactions of the APC and T cells’ molecules
in the Leishmania infected scenario. Hence, the recon-
structions of the complete inter- and intra-cellular
signaling cascades regulating the APC and T cell func-
tions are performed.
3.2 Features of the reconstructed pathway
In Fig. 1, a simplified version of the newly reconstructed
pathway diagram is presented to provide the brief de-
scription of the entire reaction cascade. In this simplified
figure, the major inter- and intra-cellular signaling
events triggered by important molecules (e.g., MHC,
CD40, IL10 etc.) of both the cells and pathogen are pro-
vided for the sake of simplicity.
The complete diagram of the newly reconstructed
Leishmania-APC-T-cell pathway model is provided in
Additional file 4: Figure S3. It integrates all possible
inter-cellular and intra-cellular signaling events that
occur between the two immune cells during Leishmania
invasion. Here, the interaction of the Leishmania mole-
cules, produced from the promastigote and the amasti-
gote forms, with the APC molecules are considered
separately. The entire signaling network (i.e. intra- and
inter-cellular) consists of a total of 293 nodes, which in-
cludes 82 APC molecules, 206 T cell molecules, and 5
Leishmania-related molecules, that are involved in more
than 400 protein-protein interactions. The intra-cellular
signaling cascades considered for modeling the APC and
the T cell consists of the major co-receptor signaling
pathways, the cytokine pathways, TLR pathways, etc.
that play a pivotal role in regulating the outcome of the
immune cell’s functional responses. In case of APC, the
pathways, which are considered in our model, include
the CD40 pathway, the interleukin pathways (viz. IL4,
IL6, and IL10), TLR pathways (TLR2, TLR3, TLR4), and
the pathways involved in TNF_ALPHA, IFN_GAMMA
signaling. Again in T cell, in addition to the core TCR-
mediated signaling, seven co-receptor signaling pathways
(viz. CD28, CD27, LTBR, CTLA4, ICOS, PD1, and
OX40), cytokine pathways (viz. IL1, IL2, IL10, IL12,
TNF, and IFN-mediated pathways) and the CRAC
channel-mediated calcium pathway are considered.
Various crosstalk reactions are also considered in the
model, which depict the bi-directional regulation that
exists between the two immune cells. These crosstalk re-
actions mainly comprise of the juxtacrine signaling
events stimulated directly by binding of the co-receptors
and the ligand molecules expressed on the T cell and the
APC membranes, and the paracrine signaling that are
mediated by the diffusible output molecules (mostly cy-
tokines) produced by each cell. Overall 10 crosstalk in-
teractions between the T cell and the APC that
effectively regulates the expression pattern of each other
are considered. These includes IFN_GAMMA_T, IL4_T,
IL6_T, IL10_T, TNF_ALPHA_T molecules secreted from
the T cell, and IFN_BETA, TNF_ALPHA, IL12 secreted
from the APC that diffuses and activates their
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corresponding receptor/co-receptors on their neighbor-
ing cell to trigger their downstream signaling cascades.
The co-receptor ligand molecule interaction considered
to be the most important in the model is the one that
involves the binding of the CD40 and CD40L_T mole-
cules [3].
The signaling events that begin at the membrane
region is then considered to transduce the signal
downstream to activate the major signaling pathways,
such as, the MAPK, JNK, NFKB, JAK-STAT cascades,
which activate a series of transcription factors, that
eventually transcribes the output molecules. During
Leishmania invasion, the antigenic molecules pro-
duced by the pathogen activate certain phosphatases
(e.g. SHP1, PTP1_B, TCPTP etc.) that interfere with
the signaling events of the APC. The antigen mole-
cules considered in the network, such as LPG_L,
GP63_L and EF1_Alpha, are shown to have a direct
effect on the activities of the ERK1/2 and AP1 tran-
scription factors, the former being upregulated and
the latter inhibited or degraded (a detailed description
of all the signaling events have been provided in Add-
itional file 1: Text S3).
3.3 Model analysis
3.3.1 Attractors
The Boolean attractor analysis performed on 20 inde-
pendent random samples in the uninfected and the
infected scenarios have been plotted in Fig. 2. Here,
128 combinations of input in each of the 20 samples
have been grouped together with a specific color
code. For simplicity, for the attractor only the se-
quence of logical states of the molecules in the order
of IFN_BETA, IL10, IL12, IL1_ALPHA, IL1_BETA,
INOS, IP10, NO, TNF_ALPHA, and c_FOS, is
depicted in the network graph. The results of the
analysis reveal that given all the FACTORs regulating
alternative splicing is assumed to be in ON state, all
the 2560 combinations of input (called basins of at-
tractor; each basin is represented as a node in the
network graph) in the uninfected scenario, reaches
the same Boolean attractor (…0111110111…) (Fig. 2a),
while in the infected scenario four different attractors
are obtained, viz. (…1100001011…), (…0101100011…),
(…1101101011…) and (…0100000011…) (Fig. 2b).
However, it is to be noted in the infected scenario,
2000 among the 2560 basins (i.e., 78.125 %) reached
Fig. 1 Simplified pathway diagram showing the Leishmania-APC and T cell interaction. The diagram shows the juxtacrine and paracrine
regulations between the different cells. The Leishmania antigen molecules are shown in orange. The cytoplasmic and nuclear proteins of
the APC and T cell are color coded as blue and peach respectively. The target molecules that are produced as output by the two cells
are colored green (for protein) and deep-pink (for non-protein molecules)
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the (…1100001011…) attractor (including both steady
state and cyclic attractor), hereby referred as the
major attractor of the system in the infected scenario.
These 2000 basins of the major attractor spans all the 20
random samples selected, among which 13 samples exclu-
sively drive to the major attractor, while the remaining 7
samples reach multiple attractors. The (…1101101011…),
(…0100000011…), and (…0101100011…) attractors have
been attained from 9.375, 9.375, and 3.125 % basins,
respectively.
3.3.2 Model validation with experimental data
The temporal expression profiles of the APC output
molecules viz. c_FOS, IL1_ALPHA, IL1_BETA, IFN_-
BETA, IL10, IL12, IP10, INOS, NO, TNF_ALPHA in the
infected (red) and the uninfected scenarios (green) are
plotted along-with the binarized microarray data at 0, 2,
4 and 8 h time-points (black diamond) in Fig. 3. This
figure depicts that the expression levels of all the 10 out-
put molecules are reaching the steady state values either
at 1 (i.e., up-regulation) or 0 (i.e., down-regulation).
Here, we observe that expression value of the output
molecules at steady state is exactly similar to the value
obtained as the major attractor of the system in both the
uninfected as well as the infected scenarios (Fig. 2).
Qualitative comparison of the expression values reveals
that out of these 10 selected output molecules, the
steady-state expression value of total 7 molecules viz.
c_FOS, IL1_ALPHA, IL1_BETA, IL10, IL12, INOS, and
NO in the infected scenario show the exact match with
the experimental observations [46]. While c_FOS and
IL10 show an expression value of 1 (high expression) in
the infected scenario, the other output molecules such
as IL1_ALPHA, IL1_BETA, IL12, INOS, and NO have
an expression value of 0 (low or no expression) in the
infected scenario.
Also, Fig. 3 depicts that at “4 and 8 h” time points,
c_FOS and IL10 proteins get upregulated in the simu-
lated infected scenario, which is exactly comparable with
the experimentally observed expression levels in micro-
array data at the same time-points. However, it should
be noted that although the expression level of c_FOS
protein at “2 h” time point in the simulated infected sce-
nario is not exactly matching with the experimental find-
ings, but the infected model is able to show the
downregulation of this protein between the intervals of
“0 to 1 h” time points. Both the proteins IL1_ALPHA
and IL1_BETA get up regulated at “1 h” time point and
subsequently get downregulated at “6 h” time point of
the simulated infected scenario. In the experimental
data, both of them get upregulated at “2 h” time-point
and get downregulated at “4 h” and “8 h” time-points,
respectively. In case of IL12, it is observed from Fig. 3
that except a small time interval between 0 and 1 h, this
protein remains in the downregulated state throughout
the rest of the time-points. The time course microarray
data of this protein also shows similar expression level
except at “4 h” time-point, in which this protein shows
upregulation. Similarly, INOS and NO also show similar
expression level at “2 and 8 h” time points as compare
to the experimental data. Altogether, the percentage of
validation of the simulated L.major infected scenario for
all the 10 selected proteins at all the three time-points,
i.e., 2, 4 and 8 h are 80, 50, and 70 %, respectively.
Also it can be observed that 9 out of 10 output mole-
cules match exactly at least at two time-points. Even
though in few cases, the simulation results of the expres-
sion values at a particular time point show an apparent
mismatch with the experimental observation at that
same time-point, but the expression pattern essentially
remains the same over time. It can be observed that al-
though the time-course expression of c_FOS from the
Fig. 2 Boolean attractor analysis in uninfected (a) and infected scenarios (b). The binary values shown in the attractor represents the logical
steady state values of 10 macrophage output proteins in the sequence of IFN_BETA, IL1_ALPHA, IL1_BETA, IL10, IL12, INOS, IP10, NO, TNF_ALPHA
, and c_FOS, respectively. Different color codes are used to represent the 20 different random samples, and within each sample, 128 nodes
represent the input combinations of 7 proteins selected randomly from 51 inputs of the model. In total, there are 2560 combination of initial
states denoting the basins of attraction for the entire system
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simulation results appear to be inconsistent with experi-
mental data, i.e., downregulation at 2 h and again upreg-
ulation at 4 h time-point, the overall dynamics of the
expression essentially remains the same over time, with
only a slight deviation of the expression levels (up or
down) observed in the respective time-points of experi-
mental and simulation data. Such deviations are also ob-
served in the expression dynamics of IL1_ALPHA, IL12,
NO, and INOS molecules. The successful validation of
the expression levels of these molecules can be used as
valuable indicators of the immune functions of the APC
and can be used for fine-tuning of our model to ensure
its proper functioning. On the other hand, Fig. 3 also
brings out the differences in the expression of the APC
output molecules due to the presence of the infection.
Here, it is observed that even though the steady state
values of the two scenarios (viz. infected and the unin-
fected) is sometimes similar, as in the cases of c_FOS,
IL10, and TNF_ALPHA, the overall temporal expression
pattern clearly indicates that the differences are emer-
ging due to the presence of antigen molecules in the
model simulation. In the uninfected scenario, the ex-
pression of the IL10 and the TNF_ALPHA remains low
(in the first few hours) as compared to the infected
scenario.
3.3.3 Comparison of uninfected and infected scenarios
The interference of Leishmania proteins in the signal-
ing cascade of APC cell not only modulates the ex-
pression of the output molecules and microbicidal
Fig. 3 Time-course expression profile of APC output molecules. Expression levels of the output molecules c_FOS, IFN_BETA, IL1_ALPHA, IL1_BETA,
IL10, IL12, INOS, IP10, NO, and TNF_ALPHA found in infected, uninfected and experimental conditions. The validation was performed by
comparing the expression levels of the infected situations (shown in red) with the microarray experimental data (black diamond)
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activities of APC, but also deregulates the expression
of the T cell output molecules by manipulating the
normal functioning of T cell activation pathway [49].
Comparing the expression of the APC output proteins in
infected and uninfected scenarios (Fig. 4a, b), the simula-
tion results show that invasion of Leishmania antigen
molecules severely downregulates the expression of IL12,
which is a potent T cell stimulator [2, 6]. Simultaneously,
the production of INOS and nitric oxide (NO) is also
greatly reduced in the infected APC, thereby rendering
the cell incapable of performing its microbicidal functions,
and creating an immune-suppressed condition, which is
favorable for the continued survival of the pathogen inside
APC [2, 3]. Besides, in Fig. 4b, the production of IFN_-
BETA, IP10 (a chemokine) also show an upregulation, in-
dicating an attempt of the APC to eliminate the pathogen
from the system [3, 25, 46]. IL1_ALPHA and IL_BETA
show minor fluctuations in expression during the infec-
tion and slight downregulation [2, 50]. The effect of Leish-
mania infection on the expression pattern of T cell output
proteins (Fig. 4c, d) becomes evident from the fact that
production of the protective cytokine from the cell, such
as IFN_GAMMA_T, is downregulated during the infec-
tion, while the productions of interleukins, such as
IL10_T, IL4_T, IL5_T, and IL6_T are upregulated, which
are mostly implicated as proteins favoring Leishmania sur-
vival [7, 49, 51, 52]. These results supported by the
previous experimental findings also strengthen the validity
of our model to a greater extent and enhances its
acceptability for further analysis.
3.3.4 Effect of infection on T cell signaling cascade
The results of Mann-Whitney U test reveals that out of
the expression of 62 proteins in the infected scenario
that exhibit a deviation from the uninfected scenario, 20
proteins get significantly deregulated (P < 0.05). The
temporal expression profiles of these 20 proteins (Fig. 5)
show that the Leishmania infection causes the signifi-
cant downregulation of the protective cytokines, such as
IFN_GAMMA_T, and enhances the synthesis of
TGF_BETA_T, and IL10_T from the T cell, which con-
tributes to the decline in the immune-competency of the
T cell and formation of an immune-suppressed condi-
tion as observed during L.major infections in susceptible
patients [5, 6, 53, 54]. It is interesting to note that while
the activation of the cytokines, such as IL4_T, IL5_T,
IL6_T, and the receptors, IL12R_T [52] and IL1R_T
[55], show fluctuations with respect to the control (unin-
fected scenario), certain other molecules, such as
RAP1_T, P19_T, C3G_T, CRKL_T, TYK2_T, and
SOC3_T, are distinctly upregulated as a result of the in-
fection. Also, it is observed that the members of the
JAK-STAT pathway, such as JAK2_T and STAT4_T are
downregulated in the infected scenario (Fig. 5b).
Fig. 4 Expression profile of T cell and APC during asynchronous simulation. (a) and (b) expression of the APC output molecules in the uninfected
and infected scenarios, respectively; (c) and (d) expression of the T cell output proteins in the uninfected and the infected scenarios, respectively
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3.3.5 Immune response and immunotherapeutic strategies
The effector molecules produced at the end of the signal-
ing processes in both T cell and APC manifest itself in the
form of a change in the phenotypic behaviors of the cell
that leads to disease clearance. Through the model, these
immune responses of the entire system are simulated
using the functions: TH_1_response (Eq. 1), TH_2_re-
sponse (Eq. 2), and NO_production (Eq. 3)—signifying
healing response (green line), non-healing response (red
line) and disease clearance (black triangular markers),
respectively (Fig. 6). The pathogen load is one of the major
factors, which determines the type of immune response
that will be elicited during the infection [4]. When the
antigens are OFF (i.e., mimicking a situation with low
pathogen load, or no infection), the Th1 and the NO
responses are higher as compared to the Th2 response
(Fig. 6a) [6, 44]. On the contrary, when the antigen mole-
cules are switched ON (i.e., infection is present), a higher
Th2-response is obtained (Fig. 6b) [4, 56].
After validating these immune response functions with
published literatures, these functions (Eqs. 1, 2, and 3)
confirm their acceptability and authenticity to study the
effect of the conventional immunotherapeutic strategies
in Leishmaniasis (i.e., IL12 and IFN_GAMMA_T), and
also to predict some immunostimulatory targets to en-
hance anti-Leishmania immunity (Table 1). Here, at first,
we have tried to study the effect of the commonly prac-
ticed IL12 (Fig. 6c) and IFN_GAMMA_T (Fig. 6d) treat-
ments and have observed that even though these
immunostimulants can enhance the Th1 response and
downregulate the Th2 response, they fail to enhance the
NO response. Thereafter, through perturbation analysis
we have been able to identify three T cell molecules (viz.
MKP_T, SHP2_T, and SHC_T) and two APC molecules
(viz. TLR3 and TLR2) that may have a positive role in
disease clearance. Single in silico mutation study of these
molecules reveals that in the MKP_T in silico knock-in
scenario (Fig. 6e), even though the Th1 response of the
NO response does not increase, the Th2 response gets
downregulated as compared to the infected scenario
(Fig. 6b). Knock-in mutation of the APC molecule TLR3
gives rise to an increase in NO response, although it has
no significant effect on the T cell response (Fig. 6f ). In
the case of in silico knock-out mutation studies, we have
observed that inhibition of SHP2_T leads to upregula-
tion of the Th1 response and downregulation of the Th2
response (Fig. 6g). SHC_T inhibition on the other hand,
does not exhibit any significant change in T cell or NO
responses as compared to the infected scenario (Fig. 6h).
However, if we use a combinatorial therapy by activating
the proteins TLR3 while simultaneously inhibiting
SHP2_T, we get a better anti-Leishmania immune re-
sponse (combination 1, Fig. 6j). Alternatively, TLR3
knock-in when combined with SHC_T OFF (knock-out)
and MKP_T ON (knock-in) can also give rise to a simi-
lar effect (combination 2, Fig. 6k). Besides these combi-
nations, interestingly we have also found that if we
inhibit only the expression of TLR2 protein in APC, a
very high Th1 response is obtained and simultaneously
the NO production is also increased drastically (Fig. 6i).
A summary of the combinatorial therapeutic strategies
and their outcomes as observed from our analysis is pro-
vided in Table 1.
Further, the results of the Boolean attractor analysis,
performed to confirm the robustness of our predic-
tions, reveal that the uninfected and infected scenar-
ios created in our model reaches to unique attractors,
viz. (…110…) and (…001…), respectively (Fig. 7 a, b).
Here, the attractor denotes the presence/absence of
the NO, Th1, and Th2 responses (Fig. 7). The at-
tractor analysis of perturbation studies reveals that
the scenario with IFN_GAMMA_T treatment leads to
Fig. 5 Expression profile of 20 T cell proteins which shows significant deregulation in Mann-Whitney U test. The heat maps depict the protein
expression pattern of the T cell signaling proteins under uninfected scenario (a) (control); infected scenario (b). Significant changes in the
expression dynamics are observed for these proteins under these two conditions, which clearly show the effect of Leishmania antigens in
the regulation of T cell signaling events
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Table 1 Unique combinations of proteins that can be used as promising immunotherapeutic targets
Knock-in Knock-out Th1 response up-regulation NO increase Th2 response down-regulation Anti-Leishmania Immunityb Figure
IL12a – Yes No Yes No 6c
IFN_GAMMA_Ta – Yes No Yes No 6d
MKP_T – No No Yes No 6e
TLR3 – No Yes No No 6f
– SHP2_T Yes No Yes No 6g
– SHC_T No No No No 6h
– TLR2 Yes Yes Yes Yes 6i
TLR3c SHP2_Tc Yes Yes Yes Yes 6j
TLR3, MKP_Td SHC_Td Yes Yes Yes Yes 6k
arepresents previously known and commonly used immunotherapeutic targets; brepresents anti-Leishmania immunity that implies to a state when Th1 and NO
response is up-regulated and the Th2 response is down-regulated; crepresents the proposed Combination 1; drepresents the proposed combination 2
treatment strategy
Fig. 6 Response dynamics of Th1, Th2, and NO in uninfected, infected, and in different treatment scenarios. a uninfected; b infected; c IL12 [ON];
d IFN_GAMMA_T [ON]; e MKP_T [ON]; f TLR3 [ON]; g SHP2_T [OFF]; h SHC_T [OFF]; i TLR2 [OFF]; j TLR3 [ON] and SHP2_T [OFF]; k TLR3, MKP_T
[ON] and SHC_T [OFF]
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a single attractor (…010…), which is distinct from ei-
ther the infected or the uninfected attractors (Fig. 7c).
However, our predicted targets, viz. TLR2 (Fig. 7d),
combination 1 (TLR3 ON and SHP2_T OFF; Fig. 7e),
and combination 2 (TLR3, MKP_T ON and SHC_T
OFF; Fig. 7f ) mostly lead to the infection-free at-
tractor (…110…) similar to the uninfected scenario.
Among these, it can be observed that all the 2560 basins
in the combination 1 scenario lead only to the infection-
free attractor (…110…) (Fig. 7e), while in combination 2,
we observe the presence of a bi-stable attractor, oscillating
between the (…100…) and (…110…) states (Fig. 7f). TLR2
mutation scenario also shows the presence of two attrac-
tors, i.e., (…001…) and (…110…). However, in all these
three perturbations the major attractor attained by the
system continues to be the desired (…110…) infection-
free attractor.
4 Discussion
Inadequate knowledge of the complete mechanism of
Leishmania invasion inside the host immune system is the
key reason for the low success in devising an effective cure
to leishmaniasis. In order to overcome this short-coming,
it is necessary to gain insight into the precise mechanism
of the regulation by which the Leishmania antigen mole-
cules takes control of the host cell’s signaling processes.
Through this in silico modeling study, we have tried to
unravel these regulatory mechanisms by focusing on three
important aspects of Leishmania immunobiology—(a)
effect of Leishmania infection on the gene expression or
Fig. 7 Attractor analysis of the uninfected (a), infected (b), and in silico treatment scenarios (c–f). Here, the binary values at the attractor states
represent only the logical steady states of NO, Th1, and Th2 responses under uninfected (a), infected (b), IFN_GAMMA_T [ON] (c), TLR2 [OFF] (d),
TLR3 [ON] and SHP2_T [OFF] (e), TLR3, MKP_T [ON] and SHC_T [OFF] (f). The logical states of the other nodes/protein molecules are not shown
here for the sake of better visualization. The color codes are kept same as used in Fig. 2
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the protein activation pattern in APC and microbicidal
activities, (b) effect of the infection on the T cell gene/pro-
tein expression pattern at the molecular level and their in-
fluence in pathway level to identify the molecular routes
by which Leishmania inhibits T cell functions, and (c)
identification of specific regulators (immunostimulators)
that could act as a regulatory switch to skew the Th1/Th2
dynamics towards the healing Th1 response and simultan-
eously enhance the NO production in order to accelerate
the parasite clearance from the host cell.
In this model, we have manually curated the complete
signaling cascades of the immune cells depicting the de-
tailed mechanism of regulation of the host protein-protein
interaction network by the antigen molecules at various
levels of signal transduction and transcriptional activities.
Here, we have been able to integrate all the possible routes
by which the antigen subverts the host immune responses
and modulates the proper functioning of the sentinels of
our immune systems, viz. the APCs and the T cells. The
model (Additional file 4: Figure S3) depicts the physical
binding of the T cell and APC receptors/co-receptors with
their corresponding ligands and the subsequent activation
mechanism of the downstream proteins in both the cells.
The model considers the activation of toll-like-receptor
proteins, present in the APC membrane, activate their
downstream proteins, which in turns diverges into import-
ant signaling routes such as the RAS-RAF mediated MAPK
pathway, canonical, and non-canonical NFKB pathway,
JAK-STAT pathway, PI3K-PLC Gamma pathway, JNK
pathway, etc., and leading to the activation of several tran-
scription factors (e.g., ERK1_2, NFKB, NFAT, AP1, STAT3,
etc.) in the nucleus, that in due course, singly or in combin-
ation with other transcriptional co-factors initiates the
mRNA transcription [39]. These mRNA are then consid-
ered to undergo alternative splicing to produce different
proteins isoforms with diverse biological functions that reg-
ulates the expression of the output molecules. These pro-
teins (principally the cytokines, growth factors, and the cell
cycle proteins) synthesized at the end of the cascade, in re-
sponse to the pathogenic invasion, manifest externally in
the form of a change in the cellular behavior, here referred
to as a “phenotypic response” viz. the Th1-response, Th2-
response, and NO-response (Eqs. 1, 2, and 3) [5].
Boolean attractor analysis reveals the presence of a sin-
gle attractor in the uninfected scenario and four attractors
in the infected scenarios, signifying that depending on the
severity of the infection and the presence or absence of
certain molecules in the system, Leishmania infection
may lead the system to multiple levels of infection with
varying protein expressions and clinical manifestations
(Fig. 2). It can also be observed that the major attractor
obtained in these uninfected and infected scenarios
matches exactly with the expression values as obtained
through our simulations using experimental data in both
the scenarios. Asynchronous Boolean simulation is also
performed to obtain an average behavior of the entire sys-
tem under different conditions. Such comparative studies
of the infected and uninfected scenarios using asynchron-
ous Boolean simulations brings out the effect of the Leish-
mania infection on the expression of the output
molecules in both the APC and the T cell (Figs. 3 and 4),
which nicely corroborates with previous experimental
studies and strengthens the reliability and authenticity of
the model outcomes. We have observed that Leishmania
infection down-regulates the production of protective cy-
tokines, such as IL12, IL1_ALPHA and IL1_BETA, and
microbicidal molecules, such as NO, and simultaneously
up-regulating the production of the chemokine, IP10 [3].
The simulation also reveals that in the infected scenario
the production of the cytokine IFN_BETA is also upregu-
lated, which is known to have protective functions but
only at low doses [25]. The T cell expression profile shows
that during Leishmania infection, the interleukin mole-
cules viz. IL10_T, IL4_T, IL5_T, and IL6_T, gets upregu-
lated, while the expression of IFN_GAMMA_T gets
downregulated (Fig. 4c, d). The higher production of the
proteins, such as IL10_T and IL4_T and repression of
IFN_GAMMA_T synthesis, produces conditions that
favor Leishmania survival [7], and skews the Th1/Th2 dy-
namics towards a non-healing response (Fig. 6b) [2, 50].
A close observation on the results of our Mann-
Whitney U test analysis (Fig. 5) also predicts some novel
and interesting facts about the signaling regulations im-
posed by the presence of the Leishmania infection at the
pathway level. Identified from our simulation, this regula-
tory mechanism of the signaling cascades is presented in
Fig. 8. It can be observed that Leishmania infection in-
creases the production of the protein IFN_BETA (green
upward arrow) and suppresses IL12 (red downward
arrow) from the APC. IFN_BETA diffuses and interacts
with their corresponding receptors on the T cell thereby
enhancing the activation of its downstream TYK2 mol-
ecule (black arrow) inside the T cell. Through this analysis,
we have tried to determine the possible role of L.major in-
fection in modulating the T-cell behavior at the pathway
level, and infer that the pathogen upregulates the mole-
cules involved in the TYK-CRKL-C3G pathway. Eventu-
ally, it enhances the production of SOCS3 and RAP1
proteins in the T cell (Fig. 8a), two potential negative regu-
lators of JAK-STAT and the RAS-mediated MAPK path-
ways, respectively (red arrow), which divulges the
probable harmful effects of the high levels of IFN_BETA
production from the APC that is known to occur during
Leishmania infection [57, 58]. Moreover, it can be ob-
served that in the T cell (Fig. 8b), the pathogen downregu-
lates the JAK2-STAT4 pathway by inhibiting the synthesis
of IL12 cytokine, which results in downregulation of
IFN_GAMMA production (red downward arrow) and a
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consequent increase in the IL4_T, IL5_T, and IL6_T ex-
pression (green upward arrow). These findings of the
changes occurring at the pathway level have helped us fur-
ther to identify the key regulators that can act as potential
immunostimulators during the infection.
Cytokine therapy is the most widely practiced method
of immunotherapy, is employed in the treatment of
Leishmaniasis. Immunologists have tried to enhance
the expression of IL12 and IFN_GAMMA, the two
most potent Th1 response stimulators, which are
known to play important role in alleviation of the
disease. But, the most common problem faced in such
immunotherapies is the inhibitory effect of the IL10
protein, which is overexpressed during the infection
that increases the susceptibility to the disease by inhi-
biting the effects of interferon-gamma treatment and
often blocking the synthesis of NO [59], thereby pre-
venting an effective anti-Leishmania immunity. In this
work, we have tried to simulate the effect of these two
immunotherapeutic strategies, viz. IL12 treatment
(Fig. 6c) and IFN_GAMMA_T treatment (Fig. 6d),
where we have observed that although they are able to
enhance the Th1 response and reduce Th2 response,
but these strategies fail to induce the NO response,
which is necessary to eliminate the disease causing
pathogen. Hence, to devise a successful combinatorial
immunotherapy, which can bypass the inhibitory effects
of immune-suppressive molecules, various molecules
that directly or indirectly influence the de-regulated T
cell pathways (i.e., JAK2-STAT4 pathway and the
TYK2-mediated IFN_BETA pathways) and TLR mole-
cules of the antigen-presenting cell are selectively
knocked-in and knocked-out separately and then in
combination (Table 1). Thereafter, a set of minimal
combinations of protein molecules are identified that
could act as regulatory switch to control the Th1/Th2
response and also effectively enhance an anti-Leish-
mania response (Table 1). These molecules include
three T cell molecules (viz. SHP2_T, MKP_T and
SHC_T), which are also implicated in various cancers
and infectious disease treatments, and two APC mole-
cules (viz. TLR2 and TLR3), which are popular targets
in many diseases including leishmaniasis [60–63]. A list
of antagonists and agonists of these molecules is pro-
vided in Additional file 1: Table S4.
Through our study, we suggest that TLR2, which is
debated to have the controversial roles in Leishmania
treatment [23], helps in the parasite survival. This agrees
with a recent experimental finding [24], and we propose
that TLR2 inhibition can be a useful strategy to up-
Fig. 8 T cell pathways deregulated during leishmaniasis. The schematic diagrams show that the infected APC produces high amount of IFN_Beta,
which in turn up-regulates the production of SOCS3 and RAP1 proteins that has negative regulatory effects on its down-stream JAK-STAT and
MAPK pathways (a); infected APC inhibits the production of the IL12 cytokine which results in upregulation of IL4, IL5, and IL6 cytokine secretion
from the T cell by regulating the JAK/STAT and IFN_GAMMA_T protein production (b). Green upward arrow–protein expression up-regulated; Red
downward arrow–protein expression down-regulated; Black arrow–activation; Red arrow–inhibition
Ganguli et al. EURASIP Journal on Bioinformatics and Systems Biology  (2015) 2015:13 Page 15 of 19
regulate Th1 and NO response (Fig. 6i). On the other
hand it can be understood that TLR3 alone may have a
positive role to play in Leishmania treatment and may
be a positive regulator of NO production (Fig. 6f ). It is
also interesting to note that although TLR2 inhibition
alone is sufficient to drastically enhance the Th1
response and the NO production (Fig. 6i), TLR3 activa-
tion requires a synergistic inhibition of the SHP2_T
molecule, a phosphatase that inhibits the activity of the
JAK-STAT pathway, to gain the desired anti-Leishmania
response (Fig. 6j). Surprisingly, it is also observed the
MAPK phosphatase (MKP_T) when upregulated may
inhibit the non-healing Th2 response (Fig. 6e). However,
MKP_P and TLR3 upregulation when combined with
the inhibition of the adapter molecule SHC_T, a positive
regulator of the MAPK cascade, can act as a useful com-
binatorial target in leishmaniasis treatment (Fig. 6k).
Nevertheless to combat leishmaniasis, it may be noted
here that since the Th1 subset of helper T cells pro-
duces inflammatory cytokines, a constant high Th1
response may often be undesirable in order to avoid
harmful side-effects, and hence the two combinations:
(1) combination 1: upregulation of TLR3 (i.e. ON
state) and downregulation of SHP2_T (i.e., OFF state)
and (2) combination 2: upregulations of TLR3,
MKP_T, and downregulation of SHC_T, can be con-
sidered as better immunotherapeutic strategies than
solitary TLR2 inhibition.
The robustness of our predicted combinations was fur-
ther confirmed through the Boolean attractor analysis,
where we observed that the major attractor attained by
all the three predicted immunotherapeutic targets re-
sembles with the infection-free attractor (…110…). This
is also observed in the uninfected scenario (Fig. 7 d–f ),
where the NO and Th1 responses are high and the Th2
response is low. In contrast, it can be observed that none
of the basins in the IFN_GAMMA_T treatment scenario
is able to move the system to this desired (…110…) at-
tractor, which clearly brings out the shortcomings of the
conventional immunotherapeutic targets (Fig. 7c). The
result of this analysis also highlights the controversial
outcomes that may be expected from targeting TLR2 (as
mentioned earlier), i.e., TLR2 knock-out may lead to two
separate attractors, (…100…) and (…110…). However, it
is to be noted that the major attractor obtained in the
TLR2 knock-out scenario is the infection-free attractor
(…110…), while only a small fraction reaches the at-
tractor (…100…), where although the NO production is
high, both the Th1 and the Th2 responses gets downreg-
ulated (Fig. 7d). Also, a comparative analysis of the com-
bination 1 and combination 2 scenarios reveals that
combination 1 may be considered a better target as
compared to the others, as this is the only scenario
where we can observe a complete reversal of the infected
scenario to a situation (…110… attractor) similar to the
uninfected scenario. However, since the combination 2
is leading to a bi-stable attractor, which is oscillating be-
tween the major attractor (…110…) and minor attractor
(…100…) states, this may also be useful in cases where a
constant high NO production is required accompanied
with an intermittent up-regulation of Th1 response for
patients pre-disposed to inflammatory diseases.
It is important to note that in order to reduce the
complexity of the model and due to lack of complete
information about the functional regulations of the
isoforms in Leishmania infected situation, we have
only focused on the alternative splicing mechanism at
the post-transcriptional level. However, this model
may further be extended to study the effect of the al-
ternatively spliced isoforms of the input molecules
[64]. For example, TLR3 mRNA molecule is alterna-
tively spliced to produce a smaller 60 kDa isoform,
which has been observed to be overexpressed in Glio-
blastoma cell lines. In future, RNA seq analysis of
Leishmania infected human APC may provide further
insight into the expression of such alternatively
spliced isoforms in case of Leishmania infection sce-
nario. This may also give a better understanding of
the precise regulatory mechanisms underlying the dif-
ferential protein expression due to the pathogenic
invasion.
5 Conclusions
The switching between the Th1/Th2 responses during
Leishmania invasion has important implications in
Leishmaniasis treatment, and hence effective regula-
tion of this switching mechanism is important for
devising a proper cure for the disease. In this work, we
have been able to capture some of the vital aspects of
Leishmania infection and the mechanism through
which the interaction of the Leishmania antigen mole-
cules with the APC signaling proteins modulate the
microbicidal activity of both the APC and T cell. Al-
though our model does not deal with the dynamics of
the entire system due to the large number of unknown
parameter sets, but through the logical analysis of the
integrated Leishmania-APC-T-cell model, we have
been able to precisely highlight the inhibitory effects
of Leishmania infection on the T cell’s signaling routes
and Th1/Th2 immune responses. Here, we suggest
that Leishmania infections enhances the secretion of
the IFN_BETA from the APC, which in turn can up-
regulate the production of the RAP1 and SOCS3 pro-
teins inside the T cell, the potential inhibitors of
MAPK and JAK-STAT signaling pathways, respect-
ively, via the TYK2-mediated pathway. The other T
cell pathway affected in Leishmania infection is the
JAK2-STAT4 pathway. Enhancing the activity of this
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pathway in the T cell by inhibition of the phosphatase
SHP2, and simultaneously regulating the activity of
the TLR3 molecule in the APC, we have also been able
to identify certain unique combinations of proteins,
which can act as regulatory switch to shift the Th2
response towards the Th1 response, and at the same
time can increase the production of NO. The study
highlights a negative role of the T cell SHC molecule
and a positive role of the MKP molecule in leishman-
iasis treatment. Attractor analysis study firmly estab-
lishes the reasons for the failure of the conventional
immunotherapeutic targets, such as IFN_GAMMA_T
treatment, and ensures that our proposed combina-
tions of protein molecules when targeted reverts the
system to an infection-free attractor. Hence, it may be in-
ferred that the proposed combinations of target molecules
can be efficiently used as potent immunostimulators to
yield an effective anti-Leishmania immune response and
expedite the process of parasite clearance from the system.
We also hope that in future this computational study will
be a useful tool for identification of important immune-
stimulatory targets for better treatment and alleviation of
leishmaniasis.
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gene co-expression network from time course activated T-cell
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expressed genes in the microarray experiment of activated T-cell.
Text S3. Brief description of the Leishmania-APC-T-cell Signaling
Pathways. Text S4. Differential regulation of different splicing
FACTORS and isoforms. Table S3. List of all known alternatively
spliced isoforms of the output molecules of both APC and T-cell.
Text S5. Logical Equations used to model the reaction mechanisms
in T-cell and APC during Leishmania infection. Text S6. Binary initial
values of the reaction nodes considered in the Logical equations from
binarization of microarray expression data. Table S4. List of agonist and
antagonist of the proposed targets (DOCX 128 kb)
Additional file 2: Figure S1. Gene clusters identified in Leishmania
major infected APC microarray data. This figure contains total 10
clusters or functional modules, which have been identified from the
gene co-expression network generated from the time course microarray
expression data of Leishmania major infected APC [EBI-ArrayExpress (ID:
E-GEOD-42088)]. The names of the nodes in all the cluster diagrams are
assigned according to the probe IDs used in HG-U133_Plus_2 Affymetrix
GeneChip for human cell. (TIF 2077 kb)
Additional file 3: Figure S2. Gene clusters identified in active T-cell
microarray data. This figure contains total 24 clusters or functional
modules, which have been identified from the gene co-expression
network generated from the time course microarray expression data
of activate T-cell [EBI-ArrayExpress (E-GEOD-48978)]. The node names
used in each cluster are in accordance with the probe IDs used in
Affymetrix HT_HG-U133_Plus_PM array plate. (TIF 4656 kb)
Additional file 4: Figure S3. Comprehensive diagram of T-cell, APC
and Leishmania pathogenic protein-protein interaction network. The
diagram presents an integrated view of the T-cell and APC interaction
signaling pathway during Leishmania infection. The different molecules
involved in the signaling cascade have been color coded according to its
type and cellular location. The molecules colored as red signify the
Leishmania antigen molecules. The interaction lines have been color
coded according to the type of chemical reaction such as phosphorylation
(blue), inhibition (red), activation (green) etc. (TIF 5212 kb)
Additional file 5: Figure S4. Attractor analysis of the uninfected and
infected scenarios under the differential activation of the splicing factors.
(A) In the uninfected scenario the system reach two stable steady state
attractors, in which the expressions of IFN_BETA, IL10, IL12, IL1_ALPHA,
IL1_BETA, INOS, IP10, NO, TNF_ALPHA and C_FOS proteins are
(0111110111) or (0110010111). (B) In the infected scenario, the system
reach two stable steady state attractors namely (1100001011) and
(1101101011), respectively. (TIF 339 kb)
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